miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling

The onset of secondary resistance represents a major limitation to long‐term efficacy of target therapies in cancer patients. Thus, the identification of mechanisms mediating secondary resistance is the key to the rational design of therapeutic strategies for resistant patients. MiRNA profiling comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliore, Cristina, Morando, Elena, Ghiso, Elena, Anastasi, Sergio, Leoni, Vera P, Apicella, Maria, Cora', Davide, Sapino, Anna, Pietrantonio, Filippo, De Braud, Filippo, Columbano, Amedeo, Segatto, Oreste, Giordano, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127885/
https://www.ncbi.nlm.nih.gov/pubmed/30021798
http://dx.doi.org/10.15252/emmm.201708746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127885/
https://www.ncbi.nlm.nih.gov/pubmed/30021798
http://dx.doi.org/10.15252/emmm.201708746

Ejemplares similares